Mycobacterium tuberculosis Exploits a Molecular OffSwitch of the Immune System for Intracellular Survival by Both, Ulrich von et al.
1SCIeNTIFIC REpoRtS |  (2018) 8:661  | DOI:10.1038/s41598-017-18528-y
www.nature.com/scientificreports
Mycobacterium tuberculosis 
Exploits a Molecular Off Switch 
of the Immune System for 
Intracellular Survival
Ulrich von Both1,2,3, Maurice Berk1, Paul-Michael Agapow1, Joseph D. Wright1, Anna Git4,7, 
Melissa Shea Hamilton1, Greg Goldgof1, Nazneen Siddiqui5, Evangelos Bellos  1, Victoria J. 
Wright1, Lachlan J. Coin6, Sandra M. Newton  1 & Michael Levin1
Mycobacterium tuberculosis (M. tuberculosis) survives and multiplies inside human macrophages by 
subversion of immune mechanisms. Although these immune evasion strategies are well characterised 
functionally, the underlying molecular mechanisms are poorly understood. Here we show that during 
infection of human whole blood with M. tuberculosis, host gene transcriptional suppression, rather 
than activation, is the predominant response. Spatial, temporal and functional characterisation of 
repressed genes revealed their involvement in pathogen sensing and phagocytosis, degradation within 
the phagolysosome and antigen processing and presentation. To identify mechanisms underlying 
suppression of multiple immune genes we undertook epigenetic analyses. We identified significantly 
differentially expressed microRNAs with known targets in suppressed genes. In addition, after 
searching regions upstream of the start of transcription of suppressed genes for common sequence 
motifs, we discovered novel enriched composite sequence patterns, which corresponded to Alu 
repeat elements, transposable elements known to have wide ranging influences on gene expression. 
Our findings suggest that to survive within infected cells, mycobacteria exploit a complex immune 
“molecular off switch” controlled by both microRNAs and Alu regulatory elements.
Mycobacterium tuberculosis (M. tuberculosis) currently infects a third of the world’s population, causing 9.6 mil-
lion new cases of tuberculosis (TB) and 1.5 million deaths annually1. Following infection with M. tuberculosis, 
90% of individuals successfully contain the pathogen but enter a state of long-term infection in which viable 
mycobacteria survive within infected cells and granulomata2. In approximately 10% of those infected, progres-
sion of infection occurs, resulting in active TB disease3. For the majority of patients with active TB, the disease 
appears to represent an immunological “stand-off ”, where despite evidence of a vigorous host immune response 
involving both innate and acquired arms of the immune system, M. tuberculosis survives and multiplies, causing 
progressive destruction of lungs and other tissues. Mycobacteria are predominantly intracellular pathogens, and 
their ability to survive within human cells, despite evidence of an active host response, appears to be explained 
by their ability to subvert multiple components of the host immune response4 (Fig. 1). These include inhibition 
of pathogen sensing (Fig. 1(1)), phagosome maturation (Fig. 1(2)) and phagolysosome fusion (Fig. 1(3)), impair-
ment of acidification of the phagocytic vacuole (Fig. 1(4)), impaired release and function of proteolytic enzymes 
in the phagocytic vacuole (Fig. 1(5)), inhibition of antigen processing and presentation and the impaired function 
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of the MHC class II system which normally presents mycobacterial peptides to CD4+ T cells (Fig. 1(6–8))5–8. 
Furthermore, proteins released from mycobacteria (i.e. ESAT6 and CFP10), also enable the pathogen to escape 
from the phagolysosome (Fig. 1(9)), and M. tuberculosis infection impairs alternative intra-cytoplasmic killing via 
autophagy and NLRP3-inflammasome activation9–11.
Despite extensive documentation of the multiple functional defects in intracellular pathogen killing (Fig. 1), 
the underlying molecular mechanisms are largely unknown. Studies that describe molecular mechanisms have 
tended to focus on individual pathways in single cell types. To explore and characterise the molecular events 
occurring during interaction of human immune cells with M. tuberculosis in a more complex biological system, 
we infected whole blood from healthy volunteers with M. tuberculosis H37Rv and performed whole-genome 
RNA profiling over a 96 h time course. This well-validated infection model12–14 has advantages over isolated cells 
or non-human models, as it includes all the elements of the human immune response (phagocytes, T- and B- 
lymphocytes, plasma proteins including cytokines)13 and may be more revealing of the interplay of the cellu-
lar and molecular mechanisms involved in a complex biological infection system over time. Furthermore, the 
model has been shown to reflect changes in the immune response to mycobacteria, including differences between 
tuberculin-positive and -negative individuals13, changes induced by human immunodeficiency virus (HIV) 
infection and following antiretroviral treatment15,16, and changes in mycobacterial growth limitation induced by 
vaccines17.
Results
We initially studied a “discovery” set of four healthy “mycobacteria-naïve” subjects (BCG-non-immunized, tuber-
culin skin test [TST]-negative) and validated the findings in a comparable second set of six volunteers. Fresh 
blood from each individual was inoculated with M. tuberculosis H37Rv and growth of mycobacteria was evaluated 
at 24 h intervals over a 96 h period, with concurrent analysis of genome-wide RNA, and expression of secreted 
and surface expressed proteins by enzyme linked immunosorbent assay (ELISA) and fluorescence activated cell 
sorting (FACS), respectively. To identify significant changes in gene transcription and determine direction (up 
or down) of differential expression over time we used a novel smoothing splines mixed-effects (SME) model18.
Figure 1. Intracellular mycobacteria evade host immunity. Cartoon showing various sites of immune 
subversion where mycobacteria are known to evade intracellular killing. References highlight key publications 
and relevant reviews showing impairment of steps 1-9 in M. tuberculosis infection. (1) Mycobacteria are 
recognized by phagocytosis-promoting receptors and engulfed within the early phagocytic vacuole63–65. 
(2) Maturation of the phagosome66–68. (3) Phagolysosome fusion and ingress of proteolytic enzymes66,69–72. 
(4) Acidification of phagocytic vacuole through activation of vATPase and NADPH-oxidase66,70,73,74. (5) 
Degradation of proteins to peptides75. (6) Cleavage of invariant chain (Ii) facilitated by HLA-DM and peptide-
loading of class II MHC76–78. (7) Transport of class II MHC and peptide from the endoplasmic reticulum (ER) to 
the plasma membrane77,79,80. (8) Presentation of peptide antigen via class II MHC to CD4+T-cells6,80,81. (9) Free 
cytoplasmic bacteria are killed by autophagy and NLRP3 inflammasome activation10,82.
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M. tuberculosis infection of whole blood causes predominantly suppression (down-regulation) 
of both gene and protein expression. The SME model is a novel and powerful method for statistical 
analysis of time-course data. After statistical correction for multiple comparisons (false discovery rate [FDR] 
q-value < 0.01), this SME model identified 3,884 probes (2,994 unique genes) in the discovery set as being sig-
nificantly differentially expressed (SDE) during infection of human blood with M. tuberculosis over the 96 h 
time-course relative to the uninfected controls (Supplementary Table S1). Of all SDE probes having a log2 FC > 1 
or <−1, 75% (766/1026) were suppressed (binominal proportion test p-value < 2.2 × 10−16) (Fig. 2a–c). Greater 
than 95% of the SDE probes in the discovery set displayed consistent direction of expression in both discov-
ery and the validation cohorts (Fig. 2b). For validation of our findings and to confirm that differential RNA 
Figure 2. M. tuberculosis induces differentially expressed transcripts during in vitro infection of whole blood. 
(a) Volcano plot showing transcripts differentially expressed in response to infection of whole blood with M. 
tuberculosis over time (0–96 h) in the discovery data set (using blood from 4 individual donors). Blue dots 
(n = 2,858) represent significantly differentially expressed (SDE) transcripts between matched infected and 
uninfected samples, and with |maximum log2FC| < 1; red dots (n = 1,026) represent SDE transcripts with 
|maximum log2FC| > 1. (b) Validation of changes in mRNA expression; correlation of |maximum log2FC| 
between SDE transcripts in the discovery and validation study (top 1000 transcripts shown). (c) Heat map 
showing timing of maximum mRNA expression of up- (red) and down- (green) regulated genes for the top 
1000 transcripts with |maximum log2FC| > 1 in M. tuberculosis infected whole blood as compared to uninfected 
whole blood. Black represents no difference in expression. The relative degree of transcript abundance is 
indicated by the colour intensity derived from the fitted mean expression levels over time (see methods).
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expression reflected changes at the protein level, we measured a selection of secreted and cell-associated proteins 
(TNF-α, IFN-γ, HLA-DM) by ELISA and FACS respectively, encoded by SDE transcripts. Protein expression 
paralleled the changes in gene expression (Supplementary Fig. S1).
Cellular location, biological function and timing of gene expression. To explore the biology of the 
transcriptional response we used functional databases (Ingenuity Pathway Analysis [IPA®] and KEGG pathways 
[http://www.genome.jp/kegg/pathway.html]) to assign SDE genes to functional categories, cellular location and 
canonical pathways. We found a striking predominance of down-regulated genes whose proteins are components 
of the cell surface (Fig. 3a). Of all 381 SDE genes coding for surface expressed proteins, including cellular rec-
ognition receptors, signalling molecules and integrins, 67% were down-regulated after M. tuberculosis infection 
over 96 h. When looking at genes with a max. log2 fold change (FC) < −1 and >1 (n = 203) the percentage of 
down-regulated genes increased (82%).
Figure 3. Balance of up- and down-regulation of significantly differentially expressed (SDE) genes in response 
to M. tuberculosis infection of whole blood over a 96 h time course. (a) Proportion of SDE genes coding for 
surface expressed proteins showing up- or down-regulation over 96 h. Red = up regulated genes; green = down-
regulated genes (q < 0.001). Down-regulation is the predominant response to infection, proportion of down-
regulated genes increases with effect size, represented by |log2FC|. (b) Assignment of early (0–48 h) and late 
(48–96 h) SDE genes to canonical pathways (IPA®) according to timing of infection. Height of individual bars 
corresponds to percentage relative to total number of genes (top of each bar) assigned to respective pathway. 
Red = up-regulated, green = down-regulated genes. Orange dots show the −log(B–H adjusted p-value) for each 
pathway.
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We observed differences in timing of maximal gene expression or suppression with some genes rapidly reach-
ing their maximum FC (either up- or down-regulated) early, within the first 48 h. A second group reached max-
imum expression/repression in the 48–96 h time period (late) (Fig. 3b). These different temporal patterns of 
expression were further analysed by biological pathway and function. Early SDE genes were those largely involved 
in granulocyte and agranulocyte adhesion and diapedesis, activation of IL-17, peroxisome proliferator-activated 
receptor (PPAR) and TNFR1 signalling, FCϒ receptor-mediated phagocytosis in macrophages and monocytes, 
as well as chemokine CCR5, IL-8 and IL-10 signalling.
In contrast, late SDE genes were those involved in T- and B-cell signalling, communication between den-
dritic cells and natural killer cells, TREM1 signalling, communication between innate and adaptive immune cells 
and antigen processing and presentation. We also observed differences in the balance between up-regulation 
and down-regulation of genes according to timing. Increased transcript abundance predominated in the early 
time-points while genes less abundant became the predominant pattern at later time -points (Fig. 3b).
The predominance of down-regulation of surface expressed molecules and repression of genes in key path-
ways known to be involved in mycobacterial immunity is highlighted by Toll-Like Receptor (TLR) (Fig. 4a1–2), 
pattern recognition receptor (Supplementary Fig. S2), and TREM1 signalling pathways (Supplementary Fig. S3). 
For each of these key signalling pathways the initial up-regulation (early 0–48 h) of signalling molecules such 
as IRAK1 in the TLR signalling pathway (Fig. 4a1), NF-κB, TNF-α and IL-6 in the pattern recognition receptor 
pathway or TNF-α, IL-6, IL-8, MIP-1α and MCP-1 in the TREM1 signalling pathway is followed at the later time 
points by repression of multiple components including TLR-1, TLR-4, TLR-6, IRAK1, CD14, DECTIN1, DAP12 
and CD11c.
To determine that the increased proportion of down-regulated genes was not due to the presence of cell death, 
a trypan blue exclusion experiment on peripheral blood mononuclear cells (PBMC) and FACS analysis on whole 
blood was undertaken to assess viability of cells in the M. tuberculosis infected and uninfected samples over the 
96 hour time-course. Whilst there was a 55% reduction in total PBMC over 96 h across all samples there was 
Figure 4. Expression of key biological pathways involved in M. tuberculosis recognition and intracellular 
killing. Significantly differentially expressed genes in response to M. tuberculosis infection of whole blood 
over 96 h, relative to uninfected whole blood controls, are up-regulated (coloured in red) or down-regulated 
(coloured in green). Intensity of colour indicates degree of transcript abundance. Genes coloured in blue did 
not reach significance. All pathways are generated using (IPA®) unless stated. (a1) Early (0–48 h) surface 
expressed receptors in the TLR pathway; (a2) Late (48–96 h) surface expressed receptors in the TLR pathway; 
(b) Clathrin-mediated endocytosis pathway (0–96 h); (c) Phagocytic vacuole pathway (using Kegg Pathway 
analysis, www.kegg.jp/kegg/83–85)- acidification and proteolytic digestion within the phagolysosome (0–96 h); 
(d) Antigen processing and presentation pathway (0–96 h).
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no significant difference between the uninfected and infected samples for each donor (n = 2) (Supplementary 
Table S2). Using FACS analysis there was a reduction (<15%) in total cell viability of peripheral blood leucocytes 
(PBLs) as a consequence of time rather than infection. At 96 h there was greater than 86% monocyte viability, and 
100% lymphocyte viability in the infected compared to uninfected samples, however we did observe a marked 
reduction (78%) in the viability of short-lived granulocytes (CD8+ neutrophils) as a result of both time and 
infection (Supplementary Table S3). To confirm that the reduced RNA expression was not a consequence of the 
reduction in neutrophils or monocytes during the time course, we compared the direction of gene expression in 
our data set with data from Tailleux et al.19 who investigated RNA expression in isolated macrophages and den-
dritic cells infected with M. tuberculosis, at 48 h post-infection. We found 100% concordance of all SDE genes at 
this time-point that matched by name and direction of expression (down-regulation) in both data sets (69 out of 
141 genes, 49%). (Supplementary Table S4). We also confirmed viability of mycobacteria in all infected samples 
(0–96 h) by colony forming unit (CFU) analysis.
Genes involved in intracellular killing are repressed. To explore how gene repression or activation 
might relate to the functional defects in phagocytosis, phagolysosome fusion, acidification of the phagocytic vesi-
cle and antigen processing and presentation observed in M. tuberculosis infection, we explored the pattern of gene 
expression or repression in these pathways. We found predominant down-regulation of gene expression in all 
stages of the phagocytosis and antigen presentation pathways over the 96 h time-course (Fig. 4b–d). The majority 
of genes of the clathrin-mediated endocytosis pathway and adapters required for the formation of clathrin coated 
membrane invagination were down-regulated, including multiple components of clathrin, epsin, calcineurin and 
β-arrestin as well as DAB2, RAC1, SNX9 and PICALM. In addition, genes acting through the RTK receptor were 
repressed, including IGF1, PDGF, VGEF and FGF (Fig. 4b).
Enzyme systems required for acidification of the phagolysosome were down-regulated (Fig. 4c). The 
multi-component enzyme v-ATPase, which functions to pump hydrogen ions into the phagocytic vesicle, 
showed down-regulation of multiple components. Similarly there was marked repression of key components 
of the NADPH oxidase system required to generate reactive oxygen species, such as RAC1, NCF2 (also known 
as p67PHOX) or NCF4 (also known as p40PHOX). The enzyme systems required to degrade proteins within the 
phagolysosome including myeloperoxidase (MPO), almost all variants of the group of serine/cysteine proteases 
(cathepsin A, B, C, E, F, H, K, L1, L2 and S) and legumain (LGMN) were also suppressed. The antigen processing 
and presentation pathway showed down-regulation of multiple components, including CLIP, and class I and II 
MHC α and β (Fig. 4d). We also found down-regulation of genes in the NLRP3 inflammasome, including NLRP3, 
PYCARD (also known as ASC), CARD6, CARD9 and NLRC4, while the process of autophagy was not significantly 
affected.
MicroRNAs are significantly associated with gene expression during infection of whole blood 
with M. tuberculosis. As microRNAs (miRNAs) have been implicated in gene regulation at the 
post-transcriptional level20–22, particularly in gene silencing, we studied the full 96 h time course of miRNA 
expression concurrently with mRNA expression in response to M. tuberculosis infection. We found 97 miR-
NAs SDE (q-value < 0.001, log2 FC > 0.25 or <−0.25) during the course of M. tuberculosis infection of whole 
blood (Fig. 5 and Supplementary Table S5). For these miRNAs we found a significant over-representation of 
Figure 5. M. tuberculosis infection of whole blood induces differential expression of micro RNAs (miRNAs). 
Volcano plot showing differentially expressed miRNAs (probe level) in response to M. tuberculosis infection 
of whole blood over time (0–96 h, discovery set, using whole blood from 4 individual donors) in infected 
compared to uninfected, matched subjects. Black dots represent non-significant miRNA transcripts, blue 
dots (n = 71) SDE transcripts with a |maximum log2FC| < 0.25 and red dots (n = 50) SDE transcripts with 
a |maximum log2FC| > 0.25.
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mRNA targets amongst a) all SDE mRNA transcripts and b) all SDE down-regulated mRNA transcripts, 
using the MicroRNA Target Filter of IPA® followed by a hypergeometric test statistic; p-values 6.9 × 10−31 and 
9 × 10−13 for all SDE mRNA transcripts, and all SDE down-regulated mRNA transcripts respectively. These anal-
yses demonstrated a significant association between the SDE miRNAs (both up- and down-regulated) and the 
down-regulated SDE mRNA transcripts in our whole blood mycobacterial infection model.
Down-regulation of genes is not due to changes in DNA methylation. To investigate whether 
DNA-methylation might underlie the differences in gene expression, we studied DNA methylation over time 
in the same experimental conditions as used for the RNA expression analysis, using Illumina Infinium Human 
Methylation 450 bead arrays. We did not detect any significant changes in DNA methylation between up- and 
down-regulated genes over the whole 96 h time-course (Supplementary Fig. S4).
Down-regulated genes have common upstream regulatory elements. Finally, we investigated 
the hypothesis that down-regulated genes were co-regulated, being supressed by common upstream regulatory 
regions or elements. We therefore contrasted common sequence motifs in the 1500 base pairs (bp) upstream of 
the transcription start site (TSS) of the 100 most significantly down- and up-regulated genes. No significant dif-
ference in distribution of transcription factor binding sites (TFBS) in regions upstream of down- vs. up-regulated 
genes was detected using OPOSSUM23. We next conducted a de novo search for motifs that were present more 
frequently upstream of the down-regulated than up-regulated genes. Using the heuristic motif searching tool 
‘MEME’ to compare the above sequence datasets, 8 conserved motifs were identified upstream of down-regulated 
genes exclusively, ranging from 26–36 bp (Fig. 6). Further examination of these motifs showed that many were 
occurring in regular composite patterns, subsequently referred to as “cassettes”. These cassettes were composed of 
motifs found on either strand or in either orientation.
In order to establish frequency and distribution of the different patterns of “cassettes” in all up- and 
down-regulated genes, a modified general sequence pattern (GSP)24,25 algorithm was used to recognise and enu-
merate these cassettes (Supplementary Fig. S5). A number of cassettes of varying lengths were discovered, occur-
ring in 20–40% of the examined sequences upstream of the down-regulated genes. The relationship between the 
cassettes is shown in Supplementary Fig. S6.
Cassette enumeration in sequence datasets and identification of Alu repeat elements. 
Subsequently, we counted the wider occurrence of the cassettes identified. This was performed in the equivalent 
upstream regions of the down- and up-regulated genes that were not used for discovering the motifs (1,312 and 
1,093 respectively) and for comparison from other gene datasets: 797 genes whose expression was unchanged 
by M. tuberculosis infection, and a subset of 51 down-regulated genes that were identified as associated with the 
phagosome/phagolysosome using KEGG and IPA® pathways (Supplementary Table S6). The MAST tool (part of 
MEME suite) was used to search for the motifs discovered in the initial discovery step, and then these patterns 
of motifs were searched for the cassettes found above. The enrichment (i.e. relative frequency) of each cassette 
within each dataset was calculated as the frequency of the cassette compared to the control (up-regulated) data-
set. A p-value was created for the enrichment. We found significant enrichment of each individual cassette in the 
down-regulated genes relative to both the up-regulated and unchanged genes (Table 1). We also observed signifi-
cant enrichment of 10 out of 19 cassettes within a list of 51 SDE down-regulated genes (q < 0.01) annotated to the 
phagosome-signalling pathway (Table 1 and Supplementary Table S7).
“Exemplar” sequences for each cassette were identified by finding the three cassette sequences with the most 
significant p-value (calculated by combining the p-value of each constituent motif) and extracting the associated 
sequence. BLAST analysis of the respective cassette sequences against the NCBI REFSeq database, identified 
human Alu elements as close matches which were then directly confirmed using the “human Alu elements” tool 
within the blastn suite (Supplementary Table S8). The exemplar cassettes were matched to the Alu S family, spe-
cifically the Alu Sb or Alu Sx sub-types.
Other intracellular pathogens are associated with a similar host immune transcriptional response. 
In order to establish whether the down-regulation of genes we observed is also seen when whole blood is infected 
with non-pathogenic mycobacteria, we studied RNA expression in response to M. bovis BCG, using the same 
experimental methods as described for M. tuberculosis. We found that 88% of genes showing significant differ-
ential expression in response to M. tuberculosis infection followed the same direction of gene regulation (up or 
down) when whole blood was infected with M. bovis BCG (highly significant correlation, p-value 2.2 × 10−16) 
(See Supplementary Fig. S7).
To investigate whether the down-regulation of key genes we observed following infection of human cells 
with M. tuberculosis and M. bovis BCG also occurs in response to other intracellular pathogens, we compared 
the pattern of RNA expression in our M. tuberculosis data with the reported RNA expression changes over 72 h 
in a human macrophage cell line infected with Leishmania major or Leishmania amazonensis26. As the in vitro 
infection experiment and time course of the Leishmania study were similar to that in our study, we were able to 
directly compare the log2 FC of the 1000 most SDE genes in response to M. tuberculosis with the log2 FC of the 
same genes in Leishmania infection.
Again, we observed a remarkable concordance of the direction of expression of host genes in response 
to M. tuberculosis with the genes SDE in response to both species of Leishmania (Supplementary Fig. S8 and 
Supplementary Tables S9 and S10). A Pearson correlation coefficient calculated for the respective datasets 
revealed a highly significant correlation: M. tuberculosis and L. major log2 FC: Pearson’s r = 56.6% (p-value 
2.2 × 10−16), and M. tuberculosis and L. amazonensis log2 FC: Pearson’s r = 60.5% (p-value 2.1 × 10−16). The highly 
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significant correlation between the SDE host genes in response to M. tuberculosis, M. bovis BCG and both species 
of Leishmania, suggests common mechanisms may be involved in the genomic response to different intracellular 
pathogens.
Figure 6. The workflow for motif cassette discovery and validation. (a) 100 experimental (down-regulated) 
and control (up-regulated) sequences are used for de novo motif discovery via MEME. (b) The sequences of 
motifs are reduced to strings of tokens and used by the modified general sequence pattern (GSP) algorithm to 
find cassettes of composite patterns. (c) The MAST program is used to find the motifs in non-discovery sets of 
experimental, control and comparative sequences. (d) These motif results are mined for the cassette patterns 
discovered above. (e) The enrichment of the cassettes in comparison to the control set is calculated, as is a p-
value. Note: the values shown are only for illustration purposes.
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Discussion
We used a well-validated whole blood infection model and a novel statistical method for RNA expression analysis 
over a time course to explore the human host response to M. tuberculosis infection. This SME model enables the 
expression of each individual gene over time to be calculated, allowing for an accurate and dynamic illustration 
of the transcriptional changes in infected versus uninfected samples.
We show that the predominant genomic response to M. tuberculosis infection of human whole blood 
is down-regulation of genes; 75% of the SDE genes (|maximum log2 FC| > 1) were suppressed. The dynamic 
and temporal pattern of gene expression revealed initial up-regulation of genes coding for pro-inflammatory 
cytokines followed by a later repression of a wide range of cell surface receptors required for inter-cell commu-
nication, and a down-regulation of genes in the key pathways required for intracellular killing of mycobacteria.
Profound and consistent down-regulation of genes involved in phagolysosome formation was observed, 
including the endocytic process, which is the first step in entrapment of mycobacteria within the phagolysosome. 
Most components of the clathrin-mediated endocytosis pathway were suppressed, a pathway that had recently 
been reported in the context of interaction with the M. tuberculosis Mtbhsp6027. In addition, key components of 
the enzyme systems required for acidification of the phagocytic vesicle (v-ATPase complex) and the generation 
of reactive oxygen mediated species and the phagocytic burst (NADPH-oxidase complex) were also significantly 
suppressed. Key enzymes involved in degradation of proteins within the phagolysosome were down-regulated 
including myeloperoxidase (MPO), legumain (LGMN) and almost all variants of cathepsins, as were the class I 
and II MHC α and β components of the antigen processing system leading to presentation of peptide within the 
context of MHC class II. The findings of suppression of the group of cathepsins are in agreement with a recent 
study of Pires et al., with a single exception of the CtsF gene which has been shown as activated in their study 
using monocyte-derived macrophages infected with M. tuberculosis28. Alternative pathways for killing and con-
tainment of mycobacteria outside the phagosome, including generation of the NLRP3 inflammasome showed 
similar repression of key genes.
There is always a concern that down-regulation of genes during in vitro cell culture may be caused by cell death. 
To address this issue we undertook analyses including trypan blue exclusion, FACS analysis of viable cells and 
comparative gene expression analysis with additional datasets from infection of isolated macrophages19. Whilst 
we observed a reduction in monocyte and neutrophil cell numbers over time, we also observed up-regulation of 
predominantly macrophage-expressed genes (CCL22, IL-6, IL-1A, IL-1B and IL-23A). Furthermore the mod-
est reduction in cell numbers was insufficient to explain the large log fold change in gene expression that we 
observed.
Confirmation that the differential expression of mRNA transcripts is associated with protein expression and 
function was found in the close correlation between mRNA expression and protein measurements of inflam-
matory proteins in plasma such as TNF-α and IFN-γ or the cellular expression of HLA-DM detected by FACS. 
Whilst differences in the direction of SDE genes such as NLRP329 and those in the clathrin mediated pathway27 
Cassette
Experimentala Unchangedb Phagosome-associated
Enrichment p-value Enrichment p-value Enrichment p-value
3+5− 1.159 7.49E−03 0.942 7.83E−01 1.419 3.90E−02
3−2+ 1.178 1.98E−03 0.978 6.15E−01 1.475 1.90E−02
3−6− 1.107 3.82E−02 0.931 8.41E−01 1.365 4.77E−02
5−2− 1.168 5.22E−03 0.958 7.12E−01 1.335 7.35E−02
6−4− 1.117 2.71E−02 0.946 7.79E−01 1.3 8.13E−02
8−4+ 1.138 1.08E−02 0.953 7.49E−01 1.437 2.49E−02
3−2+5+ 1.196 2.73E−03 0.978 6.02E−01 1.372 6.69E−02
3−6−4− 1.113 3.99E−02 0.891 9.33E−01 1.415 4.01E−02
6+3+5− 1.157 1.33E−02 0.909 8.73E−01 1.292 1.12E−01
6−4−8+ 1.155 1.01E−02 0.947 7.56E−01 1.369 6.01E−02
3−6−4−8+ 1.144 2.15E−02 0.888 9.22E−01 1.496 2.89E−02
4+6+3+5− 1.17 1.12E−02 0.888 9.13E−01 1.38 7.21E−02
4+6+3+5−2− 1.202 6.25E−03 0.897 8.76E−01 1.557 2.98E−02
8−4+6+3+5− 1.184 1.04E−02 0.849 9.59E−01 1.407 7.12E−02
4+6+3+5−2−3+ 1.253 2.09E−03 0.943 7.19E−01 1.617 2.72E−02
8−4+6+3+5−2− 1.219 5.86E−03 0.858 9.35E−01 1.594 3.02E−02
1+8−4+6+3+5−2− 1.251 7.55E−03 0.903 8.05E−01 1.393 1.16E−01
8−4+6+3+5−2−3+ 1.253 3.56E−03 0.897 8.42E−01 1.64 3.00E−02
1+8−4+6+3+5−2−3+ 1.306 3.02E−03 0.924 7.34E−01 1.362 1.40E−01
Table 1. Enrichment of cassettes upstream of different gene sets. Phagosome-associated genes are from the 
experimental data that were associated with the respective function or compartment based on KEGG pathways. 
Enrichment is calculated relative to the proportion of sequences containing at least one of the respective 
cassettes, relative to the control (non-discovery up-regulated) set. The p-value of the enrichment is calculated 
using the beta-binomial. P-values less than 0.05 are in bold. aExperimental dataset (non-discovery down-
regulated gene sequences), bUnchanged dataset (sequences of genes without differential expression).
www.nature.com/scientificreports/
1 0SCIeNTIFIC REpoRtS |  (2018) 8:661  | DOI:10.1038/s41598-017-18528-y
have been reported in other in vitro infection studies, and in vivo whole blood samples from patients with tuber-
culosis, differences in experimental conditions (in vivo versus in vitro infection and sample types; whole blood/
single cell types; time-points/time-course analysis) are likely to result in different responses in gene expression 
changes and direction in some reported studies.
Our analysis suggests an explanation of how the previously observed functional defects in intracellular kill-
ing of M. tuberculosis might be caused at the genomic level, and links previous findings of molecular defects in 
individual biological pathways together. We have shown that the initial genomic response to infection of human 
cells with M. tuberculosis is a short-lived burst with increased production of mRNA transcripts coding for inflam-
matory cytokines, including TNF-α, IL-6, IL-8, MIP-1α and MCP-1. However, once mycobacteria have entered 
the phagocytic cell, the genomic response appears to be down-regulation of genes coding for cell surface recep-
tors including TLRs required to recognise infected cells, and down-regulation of the key pathways required for 
intracellular killing and processing and presentation of antigens to the T- and B-cells of the acquired arm of the 
immune system. Although functional defects in phagolysosome fusion, acidification and antigen processing and 
presentation have been well established in M. tuberculosis infection5,7,8,30, our study is the first to suggest that a 
key mechanism responsible for impaired function of these inflammatory pathways might be repression of genes 
coding for production of proteins in each of these pathways.
Our finding that down-regulation of immune gene transcription is a predominant response to M. tuberculo-
sis infection raises the question of how repression or inactivation of such a large number of genes is mediated. 
The silencing of a very large number of genes (more than half of the response) may be mediated by a common 
epigenetic event rather than through production of specific transcription factors22. Since miRNAs have been 
shown to regulate expression levels of target genes, we explored the relationship between mRNA and miRNA 
expression. A high proportion of the genes that were repressed in response to mycobacterial infection are known 
targets for miRNAs showing significant differential expression in our experiment suggesting that the observed 
down-regulation of multiple genes may in part be due to miRNA-mediated regulatory processes. Some SDE miR-
NAs, including hsa-miR-155, hsa-miR-223 or hsa-miR-132 have already been highlighted by various studies in 
the context of immune regulation and pathogenesis of M. tuberculosis infection. For example, CXCL2, CCL3, and 
IL-6 have been identified as direct targets of hsa-miR-223; hsa-miR-155 has been shown to modulate the function 
of SHIP1- a negative regulator of the PI3K/Akt pathway, and stimulation of monocytes with lipopolysaccharide 
(LPS) induced expression of hsa-miR-13231, and hsa-miR-15520,21,32. In addition, hsa-miR-582-5p33, hsa-miR-
99b34, hsa-miR-125a35, hsa-miR-26a31 and hsa-miR-32* have also been shown to be affected in their respective 
expression in the context of M. tuberculosis infection. Still, some key miRNAs, such as hsa-miR-142-3p, were not 
SDE in our experiment, although hsa-miR-142-3p has been reported by Bettencourt et al.36 as being involved in 
phagocytosis of human macrophages. Differences in experimental conditions in whole blood models compared 
to single cell models are likely to result in different responses in expression changes to certain miRNAs.
Our findings are supported by another recent publication by Brace et al.37 showing that M. tuberculosis spe-
cifically targets negative regulatory pathways to augment immunopathology in macrophages following in vitro 
infection with M. tuberculosis H37Rv. The authors found global suppression of the MMP-inhibitory pathways in 
macrophages that were attributed to miRNA-mRNA interaction. Of note, two key miRNAs identified by Brace et 
al.37 (hsa-miR-22 and hsa-miR-199a) have also been found to be SDE in our data, further supporting the potential 
role of miRNAs in the down-regulatory effects we describe.
In order to explore the possibility that genes showing common patterns of regulation might have common 
upstream regulatory elements, we searched the upstream regions of the differentially expressed genes and identi-
fied a series of strongly conserved repeating patterns or “cassettes” significantly enriched in upstream regions of 
down-regulated genes. These common cassettes were subsequently identified as Alu elements. We found that key 
genes annotated to the phagosome-signalling pathway and significantly repressed in response to M. tuberculosis 
infection of whole blood, showed significant enrichment for these “cassettes” suggesting that this gene regulatory 
effect plays an important role in disarming key steps of the phagosome pathway. These Alu elements are the most 
abundant transposable elements in the human genome, comprising more than a million copies and more than 
10% of all human genomic sequences38. As a short interspersed element (SINE), Alu is approximately 300 bp in 
length consisting of two similar monomers with characteristic linker and flanking sequences. Alu elements are 
grouped by sequence into several broad families, which are believed to roughly reflect their evolution and spread 
throughout the genome39,40. Alu elements contain active (i.e transposable) which are believed to have originated 
about 30 million years ago, after the split of the old and new world monkeys41. Alu elements themselves do not 
encode proteins but contain binding and promotion sites for RNA polymerase III, and thus can potentially pro-
duce Alu mRNA, although the level of expression is highly dependent upon the genomic elements surround-
ing the Alu elements, epigenetic silencing by the host genome, and progressive erosion of the Alu sequence by 
mutation.
A parasitic genetic element can interfere with gene regulation by the simple act of insertion into a cod-
ing region42, but Alu elements appear to have been coopted into a variety of regulatory roles by the human 
genome43,44. These include polyadenylation, splicing, and ADAR (adenosine deaminase acting on RNA) editing. 
Levels of Alu mRNA increase during cellular insult, possibly due to chromatin opening and SINE mRNAs have 
been shown to control the heat shock response and attenuate of transcription by binding RNA polymerase II.
The significant enrichment of Alu elements observed in our study, which we suggest is involved in regu-
lating transcriptional responses in human whole blood infected with M. tuberculosis, has also in parallel been 
observed in M. tuberculosis infected macrophages by Bouttier et al.45. Although our experimental set-up is a 
step closer to in vivo infection, their study used Chipseq analysis of H3K4 monomethylation (H3K4me1) in 
THP-1 cells infected with M. tuberculosis H37Rv for 24 h and identified regions (40%) that contained Alu S and 
J repeat elements. Examination of these Alu elements revealed transcription factor binding sites (TFBS) impli-
cated in macrophage differentiation, survival and, response to stress and infection. In addition, genes proximal 
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to H3K4me-1-associated Alu repeats were enriched for loci implicated in human innate immune defense and cell 
death pathways in M. tuberculosis infection45. Alu elements have long been known for harboring TFBS46. Though 
we identified Alu elements significantly enriched in the upstream regions of down-regulated genes, there was no 
significant difference in the distribution of TFBS between down- and up-regulated genes. This may support the 
hypothesis that it is the presence of Alu elements rather than TFBS that play an important role in down-regulating 
a large number of genes. While Bouttier et al.45 conducted their investigation using an isolated cell line and a 
predefined subset of genes, we used human whole blood and followed a genome-wide RNA analysis starting from 
the observation of a profound down regulation of genes, subsequently analyzing the subset showing the most 
significant down regulation. Thus, in the context of a growing body of literature on the regulatory roles of “selfish” 
genetic elements, the sequences we have identified as Alu elements may be coopted as upstream gene regulatory 
elements that control the down-regulation of genes involved in immune response to mycobacteria – an effective 
off-switch mechanism promoting the intracellular survival of M. tuberculosis in the human host. Although further 
investigation of the mechanisms underlying the association of the Alu elements with the gene expression changes 
we have observed is needed, it is also possible that other long-range regulatory mechanisms remain to be identi-
fied as we have only searched the region immediately upstream of each gene promoter.
The human immune system is remarkable in the speed in which it responds to the microbial pathogens to 
which we are all exposed throughout life. This inflammatory response successfully eliminates most invading 
pathogens, or localizes them to the site of infection until the cellular and antibody responses of the acquired 
immune system develop. Despite the evolutionary success of the human immune and inflammatory system in 
ensuring our survival in the face of the myriad of microbes to which we are exposed, excessive or uncontrolled 
inflammation is associated with severe illness, organ dysfunction and death, as occurs in conditions such as 
systemic inflammatory response syndrome or septic shock47. It is, therefore, not surprising that the diversity of 
the inflammatory responses to pathogens have been matched by an equally varied and powerful set of biological 
responses which have evolved to down-regulate the inflammatory process and localise inflammation at the site of 
infection. The two systems: activation of inflammation and down-regulation of the inflammatory response exist 
in a carefully balanced “yin/yang“-duality which functions to prevent either excessive inflammation or ineffective 
immune responses - both of which can be damaging to the host.
We hypothesise that the widespread suppression of gene transcription, particularly those involving key 
inflammatory pathways, which we have observed in response to M. tuberculosis infection, may indicate the func-
tion of a molecular “off switch” within the immune system which is activated to prevent excessive or uncontrolled 
inflammation. Silencing of immune response genes may not be unique to M. tuberculosis infection but may rep-
resent a common mechanism for down-regulating excessive inflammatory responses in many other infections. 
This hypothesis is supported by our finding that gene expression in whole blood infected with M. bovis BCG, is 
remarkably similar to that observed with M. tuberculosis infection, with a predominance of down-regulated genes 
in intracellular killing pathways. Furthermore, our comparative analysis of the host transcriptomic response to 
two different Leishmania species during in vitro infection of a human macrophage cell line supports this hypoth-
esis. A highly significant correlation was demonstrated between the SDE genes in the Leishmania infection data 
sets and those in M. tuberculosis and M. bovis BCG.
Although down-regulation of inflammation, through the regulatory elements upstream of specific groups of 
genes described here, may be common to many infections, the suppression of genes and pathways essential for 
containment of mycobacteria (Fig. 1) may have resulted in an immunological “window” in the immune response 
which is exploited by intracellular pathogens. We suggest that mycobacteria, and potentially other intracellu-
lar pathogens, may have evolved to exploit the common “molecular off switch” of the immune system, which is 
responsible for down-regulating inflammation, to enable their intracellular survival. Our data suggests that the 
functioning of this “off switch” is in part mediated by both miRNAs and Alu elements upstream of the suppressed 
genes.
Materials and Methods
Mycobacterial strains. All M. tuberculosis culture and infection work was undertaken in the Section of 
Paediatric Diseases, Imperial College London in a Containment Level 3 laboratory adhering to Imperial College 
London safety practices and policies. All M. bovis BCG work was undertaken at the same institute within a 
Containment Level 2 laboratory. All class 2 and class 3 mycobacterial work has been notified to the Health and 
Safety Executive (HSE) and consent to work with such organisms has been approved.
M. tuberculosis H37Rv (M. tuberculosis) was obtained from the American Type Culture Collection (ATCC, 
U.S.A). M. bovis BCG lux (BCG, Montreal strain) obtained from Professor Young’s lab (Imperial College London) 
was transformed with the reporter plasmid construct pSMT1 as previously described in detail elsewhere12.
Mycobacterial growth conditions. M. tuberculosis and M. bovis BCG were grown in a shaking incu-
bator at 37 °C until mid-log phase in Middlebrook 7H9 broth (Difco, MI) medium containing 0.2% glycerol 
(Sigma-Aldrich), 0.05% tween 80 (Sigma-Aldrich), 10% ADC enrichment (Difco, MI). 50 ug/ml hygromycin 
(Roche) was added to M. bovis BCG cultures as antibiotic selection marker. Aliquots were frozen in 15% glycerol 
and stored at −80 °C. The number of colony forming units (CFU)/ml was determined by serial dilution on 7H11 
agar (Difco, Detroit, MI) containing 0.5% glycerol, 10% oleic acid-albumin-dextrose-catalase (Difco, MI) enrich-
ment. Prior to infection assays, a vial of mycobacteria was defrosted and grown to mid log phase. Cultures were 
centrifuged at 3200 rpm for 10 minutes, supernatant decanted and the cell pellet was resuspended in phosphate 
buffered saline (PBS) (Sigma-Aldrich) and further diluted in PBS to the required mycobacterial inoculum.
Human subjects. Ethical permission for this study was granted by the Local Research Ethics committee - 
Queen Square (Ref no 11/LO/0823). All healthy adult blood donors gave written informed consent to participate 
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in this study. All personal data remains confidential via anonymisation and all results have been de-identified. All 
blood sampling and experiments were in accordance with the relevant guidelines and regulations.
Twenty millilitres of peripheral whole blood was taken from healthy adult donors recruited at Imperial 
College London (Discovery set, n = 4; Validation set, n = 6 for M. tuberculosis infection experiments; discovery 
set n = 4; validation set n = 5 for M. bovis BCG infection experiments). Donors ranged in age from 27–54 (mean 
37 years) and all were BCG non-vaccinated, purified protein derivative (PPD) negative, and ELISPOT negative to 
standard mycobacterial antigens. Whole blood was diluted 1:1 in RPMI (Sigma-Aldrich) and 2 ml aliquots were 
dispensed per bijou tube.
Whole blood mycobacterial infection assays. We used a modified version of a well-established whole 
blood mycobacterial infection model13,17. In total, two different infection assays were performed corresponding 
to a discovery and validation assay set for both M. tuberculosis and M. bovis BCG. In brief, mycobacteria were 
inoculated into the 2 ml aliquots of diluted whole blood samples to give a final inoculum of 1 CFU: 1 mono-
cyte (multiplicity of infection [MOI] 1:1) assuming an average of 2 × 105 monocytes/ml of diluted whole blood. 
Uninfected whole blood samples served as matched controls at each time point. In each experiment, all samples 
(discovery: n = 4 donors; validation: n = 6 donors for M. tuberculosis; discovery set n = 4; validation set n = 5 for 
M. bovis BCG infection experiments) were incubated for up to 96 h at 37 °C on a rocking shaker at 25 rev/min. At 
sequential time points (Discovery set 0, 6, 24, 48, 72, 96 h; Validation set 0, 24, 48, 72, 96 h), Trizol LS (Invitrogen) 
was added (3:1) to each infected/uninfected whole blood sample, samples inverted and stored at −80 °C until 
subsequent RNA extraction.
Viability and growth control of mycobacteria in whole blood samples. Viability and growth of 
mycobacteria (measured as colony forming unit [CFU]) in whole blood samples was assessed in duplicate at 0 
and 96 h by plating onto 7H11 agar containing 10% OADC enrichment in triplicate and incubating at 37 °C for 14 
days. Growth was determined by calculating numbers of CFU at T96/T0.
ELISA. Simultaneously infected and uninfected whole blood aliquots (duplicate) corresponding to each donor 
were spun at 3200 rpm for 10 min as described above, supernatants harvested and stored at −20 °C until assayed. 
TNF-α, and IFN-γ production was measured in the supernatants in duplicate at 24 h intervals for up to 96 h, 
using commercially available Eli-pairs (BD Biosciences, USA) according to manufacturer’s recommendations. 
All data quoted are median values.
Fluorescent activating cell sorting (FACS) analysis. Whole blood was lysed by diluting in lysis buffer 
(1x) (Biolegend) and washed in cold FACS buffer to retrieve a leukocyte pellet. Cell populations were distin-
guished by fluorescently labelling using a previously optimised polychromatic staining panel; LIVE/DEAD® 
Fixable Blue Dead Cell Stain Kit (Invitrogen), CD18 PECy5, CD66b PERCPCy5.5, CD14 BV421, HLA DR 
BV510, CD15 605, CD20 AF700, CD19 APC Cy7, HLA DM PE, CD3 PECF594, and HLA ABC (BD Biosciences). 
Relevant fluorescence minus one (FMO) controls and negative controls were used to identify positively stained 
populations. Lymphocytes, monocytes and granulocytes were identified by size forward scattered light (FSC)/ 
side scattered light (SC]) and then further phenotyped into live CD3− CD14+ monocytes, CD3+ lymphocytes, 
CD3− CD19/CD20 expressing B cells and CD66b/CD15 positive neutrophils. Flow cytometry was performed on 
the Fortessa instrument (BD Biosciences) and data analysed using ‘Flow Jo’ (Tree Star) software.
Trypan blue exclusion. PBMCs were extracted from whole blood of two healthy adult ‘naïve’ donors (BCG 
non-immunised, PPD negative) and infected with M. tuberculosis (MOI PBMC: CFU, 1:1). Uninfected sam-
ples served as controls. All whole blood experiments were performed in triplicate for each time-point (0, 48, 
72 and 96 h) and cell viability was determined by counting the numbers of viable cells using a basic light micro-
scope. Duplicate counts for each time-point were undertaken by two researchers, samples blinded and the results 
averaged.
RNA extraction, concentration and quality determination. RNA was extracted using the RNeasy 
and miRNeasy whole blood RNA extraction kit (Qiagen, Valencia CA) for mRNA and miRNA respectively 
according to the manufacturer’s protocol and stored at −80 °C. Extracted amounts of total RNA were assessed for 
quantity and quality, using the NanoDrop 1000 (PeqLab Biotechnologie, Germany). For additional quality and 
RNA-integrity checks, samples were run on the 2100 Bioanalyzer (Agilent Technologies, Inc.). Only samples with 
a RNA integrity number (RIN) of 7 or above were taken forward for further analysis.
cDNA amplification and processing of Illumina coding RNA arrays. The Illumina TotalPrep RNA 
amplification kit (Applied Biosystems) was used to convert samples to biotin labelled cRNA that was directly 
hybridised to the Illumina HumanHT-12 v4 Beadchip (47,231 probes) (Illumina Inc. CA, USA) according to man-
ufacturer’s procedures. After washing, blocking and staining, arrays were scanned using an Illumina Beadarray 
reader according to manufacturer’s instructions (Illumina Inc, CA, USA). Data was imported to Genome Studio 
software and the microarray images were inspected for artefacts and QC parameters were assessed. Mean raw 
intensity values for each probe were corrected for local background intensities and a robust spline normalisation 
(combining quantile normalisation and spline interpolation) was applied to each array.
Labelling, hybridization and processing of Agilent non-coding RNA arrays. Total RNAs from 
whole blood samples were extracted using miRNeasy (QIAGEN). Labelling, microarray hybridization, washing, 
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scanning and feature extraction were performed as in Dvinge et al.48. In brief, 100 ng RNA samples were labelled 
using Agilent miRNA Complete Labelling and Hyb Kit (p/n 5190-0456) and MicroRNA Spike-In Kit (p/n 5190-
1934) without additional column-based purification. Labelled samples were hybridized to custom Agilent 8 × 60k 
arrays and washed using Gene Expression Wash Buffer Kit (p/n 5188–5327) following manufacturer’s recommen-
dations with the following modifications: (a) prior to labelling RNA samples were vacuum-dried to completion 
at 45 °C; (b) hybridization volume was increased to 50 μL by addition of 1x Hi-RPM; (c) hybridization took place 
over 44 h. Microarrays were scanned on an Agilent Microarray Scanner (G2565CA) using miRNA_107_Sep09 
scanning protocol (Agilent). Spot intensities were then extracted using Agilent’s Feature Extraction software 
v10.7.3 following the custom grid 029140_D_20100630_ns.
Pre-processing of non-coding RNA array data. Pre-processing and normalization were performed as 
in Divinge et al.48. In brief, spot intensities were used without background correction. Outlying intra-array repli-
cates (mostly due to physical imperfections) were removed iteratively by ranking the replicates of each spots (six 
for all except control probes) by intensity, removing the replicate furthest from the median, and repeating the 
ranking and removal once more, leaving four replicate spots for each miRNA probe. Data from multiple arrays 
was normalised using qspline and downstream analyses were carried out on median values of qspline-normalised 
data.
Time-course microarray data analysis. We used a smoothing splines mixed-effects (SME) model18 to 
independently model each probe on the microarray and identify those exhibiting a significant change in expres-
sion levels over time. The SME model is a specific example of the functional mixed-effects model which has 
become popular in the analysis of replicated time course gene expression data49–51 due to its ability to handle 
missing observations, small sample sizes, few and irregularly spaced time points and subject heterogeneity that 
typifies such experiments. The resulting model for each probe can be summarised as a mean function (or anal-
ogously a curve) describing the average expression levels over time across all subjects, and individual curves for 
each subject representing their deviations from that mean. Probes showing a significant change in expression 
levels over time were identified by testing the null hypothesis that the mean curve is zero, implemented using a 
Wald test. A multiple testing correction was applied using the false discovery rate (FDR) method of Benjamini 
and Hochberg52. All time course analysis was carried out in R53 using the development version of the SME pack-
age available on GitHub (www.github.com/mberk/sme). Full details of the time-course analysis can be found in 
Supplementary Text S1.
Biological pathway analysis. Significantly differentially expressed (SDE) genes were analysed through the 
use of Ingenuity Pathways Analysis (Ingenuity Systems®, www.ingenuity.com) to give the biological functions and 
pathways represented in the dataset. A Fisher’s exact test with a Benjamini-Hochberg multiple testing correction 
was used to test if there was an association between the SDE genes and the pathway/biological function, and 
whether this was due to chance alone. Pathways were also assessed using the ratio of the number of SDE genes 
that mapped to a pathway divided by the total number of genes that existed in the canonical pathway. Mapping 
of SDE genes to individual signalling pathways was performed using IPA® and KEGG pathways (http://www.
genome.jp/kegg/pathway.html).
MicroRNA-mRNA association analysis was performed within MicroRNA Target Filter tool of IPA®. This fea-
ture uses experimentally validated interactions from TarBase and miRecords, as well as predicted miRNA-mRNA 
interactions from TargetScan. Additionally, IPA® includes a large number of miRNA-related findings from the 
peer-reviewed literature, the IPA® knowledge database.
SDE miRNAs (q-value < 0.001), both up- and down-regulated, were taken forward for analysis. In order to 
explore potential association between SDE mRNA transcripts and respective SDE miRNAs, all SDE mRNA tran-
scripts (q-value < 0.01) were selected for correlation analysis using MicroRNA Target Filter. This analytic strat-
egy was chosen to reflect the fact that an SDE miRNA, involved in the gene regulatory processes at the mRNA 
transcript level during whole blood infection with M. tuberculosis, could be either up- or down-regulated. Both 
findings would indicate an active involvement in the gene regulatory processes underway during the time course 
experiment. Lists of miRNA-mRNA relationships were filtered based on confidence level. Only “experimentally 
validated” and “highly probable” miRNA-mRNA target pairs were taken forward in the analysis. A hypergeomet-
ric test statistic was subsequently employed to calculate the significance of the respective association.
Methylation arrays. Mycobacterial infection assays were performed with M. tuberculosis using whole blood 
taken from 5 healthy adult donors as described above. Uninfected whole blood samples from the same donors 
served as controls. All samples were incubated for 48 and 96 h at 37 °C as described. At each time-point DNA 
was extracted using the QIAamp whole blood midi kit (Qiagen) according to manufacturer’s protocols with one 
amendment: following the addition of buffer AL the sample was incubated for 4 h at 70 °C rather than 10 mins to 
ensure 100% mycobacterial killing before removing the samples from the Containment Level 3 laboratory. This 
procedure showed no detrimental effects to the quality or quantity of DNA extracted which was then measured 
using the fluorometric method (Qubit, Thermo Fisher Scientific, MA), spectrophotometry (Nanodrop, Thermo 
Fisher Scientific, MA) and Tapestation (Agilent Technologies, CA, USA). 500 ng of DNA was bisulfite-converted 
using EZ-DNA Methylation kit (Zymo Research, CA, USA) according to Illumina’s modified protocol. The bisul-
phite converted DNA was amplified, fragmented, precipitated and re-suspended and then hybridised to the 
Infinium HumanMethylation 450 beadarray (Illumina, CA) before extension and staining according to manufac-
turer’s instructions. Arrays were imaged on the Illumina iScan (Illumina, CA, USA). Data was quality controlled 
using GenomeStudio software (Illumina, CA, USA). We performed background correction on the raw intensity 
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data according to Illumina guidelines to minimise technical variability, followed by exclusion of low quality array 
probes (detection p-value threshold of 10−6). The array probes were separated by colour channel (Red/Green), 
type (Type I/Type II) and subtype (M/U) and quantile normalisation of intensity values was applied54,55. We used 
the normalised intensities to calculate percentage methylation (β-values) at each marker and an empirical Bayes 
framework56 was used to mitigate batch effects, while adjusting for donor age and sex. Differential methylation 
analysis (Δbeta) at each locus, of individual markers between matched infected and uninfected samples at each 
time-point, was conducted using an empirical Bayes moderated t-statistic, which has been shown to have a more 
robust behaviour for smaller sample size experiments57. In addition we aggregated markers at the CpG-island 
level and at the gene level, to increase detection power by borrowing information across neighbouring markers. 
P-values were corrected for multiple testing using the Benjamini-Hochberg procedure52.
Search for upstream regulatory elements. Sequences upstream of TSS. Using the Biomart webservice 
(http://www.biomart.org,58), probe names of significantly down- and up-regulated genes in response to infection 
of whole blood with M. tuberculosis were mapped into gene names and then filtered to include coding genes 
only; thus pseudogenes and other non-coding entities were excluded. Note that a number of probes could not 
be canonically mapped to genes or were mapped to genes in both the up- and down–regulated sets. These were 
removed from the analysis. This procedure was also followed for a set of “unchanged” genes that had demon-
strated no significant differential regulation in the mycobacterial infection of whole blood dataset. Biomart was 
then used to download the 1,500 bp immediately upstream of the transcription start site (i.e. ATG codon) of 
each of these coding genes. This region was selected to examine only the immediately proximate elements. The 
number of sequences thus treated was 1,413 experimental (down-regulated) genes, 1,193 control (up-regulated 
genes) and 797 unchanged genes. Of the significantly down-regulated genes, a subgroup of 51 were identified as 
“phagosome-associated”, via pathway analysis as above. These were included as a biologically relevant subset of 
sequences for comparative analysis.
To ensure any shared motifs seen were not just the effect of examining duplicated and related genes, the cod-
ing regions of the down- and up-regulated genes were extracted from Biomart as described above and compared 
using the metagenomic tool usearch (http://www.drive5.com/usearch59). No matches above 50% were found.
Search for known regulatory elements. The upstream regions of down- and up-regulated genes were searched 
for known transcription factor binding sites (TFBS) using the OPOSSUM software (http://opossum.cisreg.ca/23). 
Upstream regions of the controls were used for background control purposes. No sites were found with better 
than Z-score of 10 or greater and a Fisher score of 7 or greater (limits suggested by tool authors from empirical 
studies).
Search for novel motifs. MEME60 was used to search more generally for conserved motifs in the 1,500 bp 
upstream region of the coding genes. The 100 top ranked down-regulated coding genes were used in this search, 
with 100 top up-regulated genes as the discriminative (control) gene set. The size of these subsets was used to 
limit computational demands. Based on previous experience, parameters were chosen to search for the 8 most 
significant motifs, allowing them to occur with any frequency, in either forward or reverse direction, i.e. on either 
strand. The motif size was limited to between 10–50 bases also for computational demands reasons. Several 
motifs, 26–36 bp in length, were identified. This procedure, and all subsequent steps, was automated with a com-
putational pipeline (written in Snakemake61, available on request) for reproducibility and consistency (Fig. 6).
Motif cassette discovery and assembly. Examination of the above motif patterns showed many were occurring in 
regular repeating sequences, or “cassettes”. These cassettes were composed of motifs found on either strand or in 
either orientation. For example, a cassette might be 1+2−3+: the first, second and third motifs found by MEME, 
occurring on the forward, reverse and forward strands in that order respectively. This cassette is complementary 
to 3−2+1−. Note that MEME and our discovery process, does not determine which orientation is “correct” or 
which cassette is the most significant.
A modified general sequence pattern (GSP)24,25 algorithm (Fig. 5 and Supplementary Fig. S6) was used to 
recognize and enumerate these cassettes within the above MEME results. In brief, the basic algorithm generates 
an initial pool of patterns seen from the list of motifs seen. It then proposes longer potential patterns by merging 
every possible pairing of existing patterns that overlap. For example: the pattern 1+2−3+ can be merged with 
2−3+4− to produce 1+2−3+4−. These proposed patterns are checked against the actual data and those that 
occur above a given cut-off frequency are retained with the next round of proposals. This merge-propose-filter 
cycle is repeated until no longer patterns can be found or the frequency of those found falls below the given 
cut-off. That is, GSP will find the longest pattern or patterns that occur above a specified frequency. A number of 
cassettes of varying lengths (2–8 motifs) were discovered.
This standard GSP algorithm was modified in a number of important ways. First, to find the frequencies of 
all cassettes, the GSP algorithm was repeated over a range of cut-off frequencies from 1% to 50% and the results 
combined. Second, cassettes were allowed to occur and be counted in either orientation. That is, when counting 
occurrences of 1+2−3+, the complement 3−2+1− would also be counted. Finally, before searching for patterns, 
insignificant motifs instances (i.e. those examples of a given motif falling above a significance threshold) were 
transformed into a null symbol. For example, if a sequence shows the motif pattern 1+2−3+, but the 2- instance 
is above the significance threshold, the sequence is transformed to 1+X3+, where X is the null symbol. These 
nulls are never used in building proposed patterns. Thus these insignificant motifs never appeared as part of a 
cassette but did serve to separate other motifs, breaking up potential patterns. For example, 1+X3− would never 
be matched by 1+2−, 2−3+, 1+2−3+ or 1+3+. A significance threshold of 1e-5 was used based on previous 
experience.
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Cassette enumeration in sequence datasets. To enumerate the occurrence of these cassettes in other, 
non-discovery, sequence datasets, the MAST tool (part of MEME suite62) was used. This takes the motif patterns 
previously determined in the MEME results and searches for them in other sequences.
The sequence sets targeted were the remainder of the down- and up-regulated datasets (i.e. those not used for 
the initial discovery of the motifs, 1,312 and 1,093 respectively), the unchanged genes (797), and a comparative 
subset of the down-regulated sequences (51 phagosome-associated genes). The patterns for the component motifs 
found in any cassette were extracted and given to MAST to identify and locate motifs instances within these 
sequence datasets. After transforming insignificant motifs into null symbols as above, the resulting patterns of 
motifs were then mined for the cassette patterns detected above. The fraction of sequences with cassettes in each 
dataset was calculated, as well as the enrichment relative to the control (up-regulated) sequences. A p-value for 
this enrichment was calculated using the beta-binomial distribution. A table of the genes with the cassettes found 
upstream of them was produced for the phagosome-related genes.
Consensus & database search. “Exemplar” sequences for each cassette were obtained by identifying for each 
cassette the three best instances (i.e. those with the most significant p-value, calculated by combining the p-value 
of each constituent motif) and extracting the associated sequence. The respective cassette sequences were then 
interrogated using standard blastn searches (Supplementary Table S5). Initial BLAST was performed against the 
“Reference RNA sequences” (refseq_rna) tool and subsequently using the “Human Alu elements” tool within the 
blastn suite.
Comparison of host transcriptomic data from in vitro M. tuberculosis infection with data derived 
from in vitro Leishmania infection. A comparative transcriptomic profiling analysis was undertaken 
of SDE genes from our M. tuberculosis whole blood dataset and respective host SDE genes in response to two 
Leishmania species from a study by Fernandes et al.26 to determine whether a similar pattern of host immune 
gene expression could be observed. Fernandes et al.26 performed transcriptomic profiling of human macrophages 
after infection with L. major or L. amazonensis over a 72 h time course. From the supplementary material of 
Fernandes et al.26 we obtained a list of the most SDE genes at each timepoint (4, 24, 48 and 72 h) along with the 
corresponding log2 FC. To facilitate comparison with our dataset, for each of the SDE genes we obtained the max-
imum log2 FC across all time points. We then compared the log2 FC of the most significant 1000 M. tuberculosis 
SDE genes against the log2FC of the same genes in both Leishmania infections.
Data availability. Gene expresson data from this study is publicly available at the Gene Expression Omnibus 
(GEO) under accession number GSE108363 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108363).
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